Identification of Novel Inhibitors of Urokinase via NMR-Based Screening
Citations Over TimeTop 21% of 2000 papers
Abstract
Using an NMR-based screen, a novel class of urokinase inhibitors were identified that contain a 2-aminobenzimidazole moiety. The inhibitory potency of this family of inhibitors is similar to that of inhibitors containing a guanidine or amidine group. However, unlike previously described guanidino- or amidino-based inhibitors which have pK(a) values greater than 9.0, urokinase inhibitors containing a 2-aminobenzimidazole have pK(a) values of 7.5. Thus, 2-aminobenzimidazoles may have improved pharmacokinetic properties which could increase the bioavailability of inhibitors which contain this moiety. A crystal structure of one of the lead inhibitors, 2-amino-5-hydroxybenzimidazole, complexed with urokinase reveals the electrostatic and hydrophobic interactions that stabilize complex formation and suggests nearby subsites that may be accessed to increase the potency of this new series of urokinase inhibitors.
Related Papers
- → Amidine‒ and guanidine‒based synthetic methods for CO2 capture and utilization(2023)22 cited
- → Poly(amidine)s and poly(guanidine)s ? synthesis and some properties(1979)5 cited
- [Relationships between structure and the noradrenaline depleting effects of guanidine and amidine derivatives (author's transl)].(1975)
- → Amidines and Guanidines in Natural Products and Medicines(2009)27 cited
- → ChemInform Abstract: Guanidine Synthesis: Use of Amidines as Guanylating Agents.(2016)